Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. raised its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 129.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 216,523 shares of the biopharmaceutical company’s stock after buying an additional 122,103 shares during the period. Regeneron […]

Related Keywords

Canada ,Christopherr Fenimore ,Michaels Brown ,Sanfordc Bernstein , ,Morgan Stanley ,Regeneron Pharmaceuticals Inc ,Jefferies Financial Group ,Royal Bank ,Securities Exchange Commission ,News Ratings For Regeneron Pharmaceuticals Daily ,Northern Trust Corp ,Regeneron Pharmaceuticals Price Performance ,Quarter For Regeneron Pharmaceuticals ,Nasdaq ,Regeneron Pharmaceuticals ,York Mellon Corp ,Free Report ,Street Corp ,Trust Corp ,New York Mellon Corp ,Exchange Commission ,Director Michael ,Get Free Report ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,